Pharma Industry News

Merck expects a flat tax rate in 2018 as peers see benefit from reform

Written by David Miller

Merck executives praised the U.S. government for tax reform on Friday, but the drugmaker is projecting a flat tax rate this year as many of its peers expect to see a benefit.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]